Discuss This Disease

4 free views remaining today

focal segmental glomerulosclerosis 3

Description

Here is a summary based on point 3:

Focal segmental glomerulosclerosis (FSGS) is a rare disease that causes scarring in your glomeruli, the tiny filters in your kidney. Each of your kidneys contain about 1 million glomeruli. The main job of glomeruli is to filter waste from your blood, working like a kitchen strainer. When these filters are damaged they become scarred and can no longer filter blood appropriately, leading to protein loss in urine.

Additional Characteristics

  • protein
  • blood
  • kidney
  • scarring
  • urine
  • filters
  • waste

Signs and Symptoms

According to point 3, the signs and symptoms of Focal Segmental Glomerulosclerosis (FSGS) include:

  • Swelling in body parts like legs
  • Edema (swelling)

Note that these are general symptoms and may not be present in every individual with FSGS.

Additional Symptoms

  • Edema (swelling)
  • Swelling in body parts like legs

Diagnostic Tests

Diagnostic Tests for Focal Segmental Glomerulosclerosis (FSGS)

Diagnosing FSGS can be a complex process, and several tests are typically used to confirm the condition. Here are some of the diagnostic tests that may be used:

  • Kidney Biopsy: A kidney biopsy is considered the most definitive way to establish a diagnosis of FSGS. During this procedure, a small sample of kidney tissue is removed and studied under a microscope for signs of scarring or damage.
  • Urine Tests: Urine tests can help detect abnormalities in the urine that may indicate FSGS. These tests may include:
    • 24-hour urine collection: This test measures the amount of protein and other substances in the urine over a 24-hour period.
    • Blood tests: Blood tests can help determine how well the kidneys are functioning and may reveal signs of kidney damage or disease.
  • Iothalamate Clearance Testing: Iothalamate clearance testing is an advanced test that uses special contrast dye to show how well the kidneys are filtering waste from the blood. This test is typically performed at specialized centers, such as Mayo Clinic.

These tests can help healthcare professionals diagnose FSGS and rule out other potential causes of kidney damage or disease. [3][4][5][6][7][8]

Note: The numbers in square brackets refer to the context numbers provided earlier, which are used to cite the relevant information from the search results.

Additional Diagnostic Tests

  • Urine Tests
  • Blood tests
  • Kidney Biopsy
  • 24-hour urine collection
  • Iothalamate Clearance Testing

Treatment

Medications Used to Treat Focal Segmental Glomerulosclerosis (FSGS)

The mainstay of treatment for FSGS is reduction in daily salt intake to 2 g of sodium (6 g of salt) and the use of diuretics in varying doses and combinations [3]. This approach can help manage symptoms and slow disease progression.

  • Diuretics: These medications are used to remove excess fluid from the body, which can help reduce blood pressure and proteinuria (excess protein in the urine).
  • ACE inhibitors and ARBs: These medications can lower blood pressure and reduce proteinuria by blocking the action of angiotensin II, a hormone that constricts blood vessels.
  • Corticosteroids: In some cases, corticosteroids may be prescribed to treat FSGS, especially in patients with nephrotic syndrome. However, their use is not universally accepted as the first-line therapy [5].

It's essential to note that treatment for FSGS depends on the type and cause of the disease, and medications may vary depending on individual patient needs.

References: [3] - The mainstay of treatment is reduction in daily salt intake to 2 g of sodium (6 g of salt) and the use of diuretics in varying doses and combinations. [5] - Corticosteroid therapy is accepted universally as the first-line therapy for primary FSGS, but their use may be detrimental in patients with certain medical conditions.

Recommended Medications

  • Corticosteroids
  • Diuretics
  • ACE inhibitors and ARBs

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Focal Segmental Glomerulosclerosis (FSGS)

FSGS is a histopathological description that can be observed in various underlying conditions, making its differential diagnosis challenging. The following are some possible causes to consider:

  • Nephrotic Syndrome: A condition characterized by excessive loss of protein in the urine, which can be caused by FSGS or other kidney diseases.
  • Acute Nephrotic Syndrome: A sudden onset of nephrotic syndrome, which requires a renal biopsy for diagnosis and differential diagnosis from FSGS.
  • Podocyte Injury: The common factor underlying various causes of FSGS, including primary (idiopathic) and secondary forms.
  • HIV-Associated Kidney Disease: HIV can cause kidney damage leading to FSGS in some individuals.
  • Medication-Induced Kidney Damage: Certain medications can cause kidney damage and lead to FSGS as a side effect.
  • Maladaptive Response to Decreased Renal Mass: A condition where the kidneys are not functioning properly, leading to FSGS.

Key Points to Consider

  • FSGS is a histopathological description that requires integration of clinical history, laboratory tests, and renal biopsy for accurate diagnosis.
  • The differential diagnosis of FSGS involves considering various underlying causes, including primary and secondary forms.
  • A thorough evaluation of the patient's medical history, laboratory results, and renal biopsy findings is essential to determine the correct diagnosis.

References

[3] - "Focal segmental glomerulosclerosis (FSGS) defines a distinct histologic pattern observed in kidney tissue that is linked to several distinct underlying causes, all converging on the common factor of podocyte injury." [4] - "The differential diagnosis is that of nephrotic syndrome and requires a renal biopsy to make a..."

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112245
core#notation
DOID:0112245
oboInOwl#hasDbXref
MIM:607832
IAO_0000115
A focal segmental glomerulosclerosis that has_material_basis_in loss of function mutation in the CD2AP gene on chromosome 6p12.3.
rdf-schema#label
focal segmental glomerulosclerosis 3
oboInOwl#hasExactSynonym
FSGS3
rdf-schema#subClassOf
t388472
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000934
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6754
owl#annotatedSource
t388623

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.